Publicacións nas que colabora con Jesús María Prieto Valtueña (8)

2016

  1. Gene expression analysis during acute hepatitis C virus infection associates dendritic cell activation with viral clearance

    Journal of Medical Virology, Vol. 88, Núm. 5, pp. 843-851

2015

  1. Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infection

    Molecular Therapy - Methods and Clinical Development, Vol. 2, pp. 15006

2013

  1. Helper cell-independent antitumor activity of potent CD8+ T cell epitope peptide vaccines is dependent upon CD40L

    OncoImmunology, Vol. 2, Núm. 12, pp. 1-11

2011

  1. Enhanced T cell responses against hepatitis C virus by ex vivo targeting of adenoviral particles to dendritic cells

    Hepatology, Vol. 54, Núm. 1, pp. 28-37

2008

  1. Combined immunization with adjuvant molecules poly(I:C) and anti-CD40 plus a tumor antigen has potent prophylactic and therapeutic antitumor effects

    Cancer Immunology, Immunotherapy, Vol. 57, Núm. 1, pp. 19-29

  2. Vaccination against hepatitis C virus with dendritic cells transduced with an adenovirus encoding NS3 protein

    Molecular Therapy, Vol. 16, Núm. 1, pp. 210-217

2007

  1. Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40

    Antiviral Research, Vol. 74, Núm. 1, pp. 25-35

2003

  1. Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses

    Journal of Virology, Vol. 77, Núm. 20, pp. 10862-10871